Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | HRH2 | P25021 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | CTH | P32929 | 1/20 | 0.36 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.33 |
| ▸ | NOS3 | P29474 | 1/20 | 0.32 |
| ▸ | NOS1 | P29475 | 1/20 | 0.32 |
| ▸ | NOS2 | P35228 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL9290863 | 0.98 | HRH4 (0.50) | ALDH1A1HRH4TDP1CYP1A2HRH2 | |
| Bromide SCHEMBL9290760 | 0.96 | HRH4 (0.48) | ALDH1A1HRH4TDP1CYP1A2HRH2 | |
| SCHEMBL9290865 | 0.85 | ALDH1A1 (0.41) | ALDH1A1HRH4TDP1CYP1A2HRH2 | |
| SCHEMBL9290804 | 0.79 | NPSR1 (0.40) | ALDH1A1 | |
| SCHEMBL9290792 | 0.78 | — | — | |
| SCHEMBL9685012 | 0.78 | ALDH1A1 (0.41) | ALDH1A1HRH4TDP1CYP1A2HRH2 | |
| SCHEMBL4574081 | 0.76 | SPHK2 (0.44) | ALDH1A1HSD17B10TSHRDNM1NOS3 | |
| SCHEMBL11406977 | 0.76 | — | — | |
| Hydrochloric Acid SCHEMBL4575154 | 0.74 | SPHK2 (0.43) | ALDH1A1HSD17B10DNM1NOS3NOS1 | |
| Iodide SCHEMBL5325538 | 0.74 | SPHK2 (0.43) | ALDH1A1HSD17B10TSHRDNM1NOS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1175155-A4 | METHOD FOR REDUCING A SUSCEPTIBILITY TO TUMOR FORMATION INDUCED BY 3-DEOXYGLUCOSONE AND PRECURSORS THEREOF | FOX CHASE CANCER CT (US) | 2005-10-19 | — | — | EP | disclosed |
| EP-1175155-A1 | METHOD FOR REDUCING A SUSCEPTIBILITY TO TUMOR FORMATION INDUCED BY 3-DEOXYGLUCOSONE AND PRECURSORS THEREOF | FOX CHASE CANCER CENTER (US) | 2002-01-30 | — | — | EP | disclosed |
| WO-2000062626-A1 | METHOD FOR REDUCING A SUSCEPTIBILITY TO TUMOR FORMATION INDUCED BY 3-DEOXYGLUCOSONE AND PRECURSORS THEREOF | FOX CHASE CANCER CENTER (US) | 2000-10-26 | — | — | WO | disclosed |
| US-4983604-A | Aminoguanidine derivatives | THE ROCKEFELLER UNIVERSITY (US) | 1991-01-08 | — | — | US | disclosed |
| EP-0210291-A1 | Platinum complexes of antitumor agents | AMERICAN CYANAMID COMPANY (US) | 1987-02-04 | — | — | EP | disclosed |
| US-4544759-A | Platinum complexes of antitumor agents | AMERICAN CYANAMID COMPANY (US) | 1985-10-01 | — | — | US | disclosed |